Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Data Collection × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1

Interventions

Nivolumab 21 pembrolizumab 16 Ipilimumab 12 Temozolomide 10 toripalimab 8 Blood Specimen Collection 7 Biopsy 7 Dacarbazine 6 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 durvalumab 4 Interleukin-2 4 Injections 4 Chemotherapy, Adjuvant 4 palbociclib 3 binimetinib 3 apatinib 3 aldesleukin 3 Sorafenib 3 Introns 3 Gene Expression Profiling 3 Cisplatin 3 Carboplatin 3 Canvaxin 3 Bevacizumab 3 tremelimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05641012 2022-12-07

Helioma

Institut Jean-Godinot

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡